VK
Vishal Khanna
About Vishal Khanna
Data last updated:
Vishal Khanna is a Director at Subira Pharmaceuticals Private Limited (since 2013). The companies operate in Pharma. Subira Pharmaceuticals Private Limited reported revenue of ₹45.51 Cr (FY 2024). Earlier, Vishal Khanna was a Director at Taurian Pharma Pvt. Ltd (2006–2012) and Whole-Time Director at Novomed Pharma Pvt. Ltd (2007–2008).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Oct 2013 | 2013 | ₹45.51 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Sep 2006 | 2006 | ₹1.27 Cr (FY 2024) | Active | |
| Whole-Time Director | 01 Sep 2007 | 2007 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vishal Khanna
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kavita Khanna | 05209020 | Subira Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vishal Khanna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vishal Khanna
Vishal Khanna currently holds 1 directorship: Subira Pharmaceuticals Private Limited (Director, since 08 Oct 2013, revenue ₹45.51 Cr (FY 2024)).
Vishal Khanna was first appointed on 15 Sep 2006 as Director at Taurian Pharma Pvt. Ltd. The most recent appointment on record is 08 Oct 2013 at Subira Pharmaceuticals Private Limited.
Vishal Khanna held 2 earlier board appointments: Taurian Pharma Pvt. Ltd (Director, 15 Sep 2006 to 28 Mar 2012); Novomed Pharma Pvt. Ltd (Whole-Time Director, 01 Sep 2007 to 10 Jul 2008).
The current boards of Vishal Khanna's companies include Kavita Khanna (Subira Pharmaceuticals Private Limited).